Thornburg Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
72,879
-188,014
| -72% | -$6.21M | 0.03% | 149 |
|
|
2025
Q1 | $105M | Sell |
260,893
-20,969
| -7% | -$8.43M | 0.15% | 87 |
|
|
2024
Q4 | $13.3M | Sell |
281,862
-1,620
| -0.6% | -$76.2K | 0.18% | 86 |
|
|
2024
Q3 | $15M | Buy |
283,482
+30,671
| +12% | +$1.62M | 0.19% | 76 |
|
|
2024
Q2 | $13.7M | Buy |
252,811
+169,050
| +202% | +$9.16M | 0.19% | 78 |
|
|
2024
Q1 | $5.87M | Sell |
83,761
-1,438
| -2% | -$101K | 0.08% | 147 |
|
|
2023
Q4 | $7.11M | Sell |
85,199
-22,967
| -21% | -$1.92M | 0.1% | 126 |
|
|
2023
Q3 | $3.19M | Sell |
108,166
-2,831
| -3% | -$83.4K | 0.05% | 158 |
|
|
2023
Q2 | $3.62M | Buy |
110,997
+20,603
| +23% | +$672K | 0.06% | 151 |
|
|
2023
Q1 | $3.18M | Sell |
90,394
-1,087
| -1% | -$38.3K | 0.05% | 152 |
|
|
2022
Q4 | $4.19M | Buy |
91,481
+17,283
| +23% | +$792K | 0.07% | 153 |
|
|
2022
Q3 | $3.6M | Buy |
+74,198
| New | +$3.6M | 0.06% | 160 |
|